GNH USA

Europe — EMA

Omlyclo (Omalizumab)

Omalizumab, the active ingredient in Omlyclo, is a monoclonal antibody presented as a injection for subcutaneous use. It treats moderate to severe persistent allergic asthma and chronic spontaneous urticaria in patients…

Request sourcing

1
Pack/s

What is Omalizumab?

Omalizumab, the active ingredient in Omlyclo, is a monoclonal antibody presented as a injection for subcutaneous use. It treats moderate to severe persistent allergic asthma and chronic spontaneous urticaria in patients who inadequately respond to standard treatments. GNH USA supplies Omlyclo as a licensed ...

What is Omalizumab used for?

Omlyclo ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Omalizumab
Route
Subcutaneous Use
Manufacturer
Celltrion Healthcare Hungary Kft
Origin
EU

Related products